Cosmos Health Inc. (NASDAQ:COSM – Get Free Report) was the target of a significant growth in short interest in the month of December. As of December 31st, there was short interest totalling 537,800 shares, a growth of 53.5% from the December 15th total of 350,300 shares. Based on an average trading volume of 219,100 shares, the days-to-cover ratio is currently 2.5 days. Currently, 2.9% of the company’s stock are sold short.
Insider Transactions at Cosmos Health
In other news, CFO Georgios Terzis purchased 85,778 shares of the stock in a transaction on Friday, December 20th. The stock was bought at an average price of $0.58 per share, for a total transaction of $49,751.24. Following the acquisition, the chief financial officer now directly owns 727,263 shares of the company’s stock, valued at approximately $421,812.54. The trade was a 13.37 % increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Grigorios Siokas acquired 257,334 shares of Cosmos Health stock in a transaction dated Friday, December 20th. The stock was purchased at an average price of $0.58 per share, for a total transaction of $149,253.72. Following the completion of the acquisition, the chief executive officer now directly owns 3,774,314 shares in the company, valued at approximately $2,189,102.12. This represents a 7.32 % increase in their position. The disclosure for this purchase can be found here. Over the last 90 days, insiders have purchased 569,278 shares of company stock valued at $348,841. 15.61% of the stock is currently owned by company insiders.
Cosmos Health Stock Up 2.7 %
Shares of COSM stock traded up $0.02 on Friday, reaching $0.86. 452,441 shares of the stock were exchanged, compared to its average volume of 464,086. The company has a market capitalization of $19.94 million, a price-to-earnings ratio of -0.35 and a beta of 5.57. The business’s 50 day moving average price is $0.71 and its 200 day moving average price is $0.91. The company has a current ratio of 1.44, a quick ratio of 1.24 and a debt-to-equity ratio of 0.08. Cosmos Health has a twelve month low of $0.47 and a twelve month high of $1.58.
About Cosmos Health
Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.
Read More
- Five stocks we like better than Cosmos Health
- 3 Grocery Stocks That Are Proving They Are Still Essential
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- How to Use the MarketBeat Excel Dividend Calculator
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- 3 Healthcare Dividend Stocks to Buy
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for Cosmos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cosmos Health and related companies with MarketBeat.com's FREE daily email newsletter.